Atlas Venture Life Science Advisors, LLC Portfolio Holdings

Atlas Venture Life Science Advisors, LLC

  • $799 Million
  • Q1 2024

Atlas Venture Life Science Advisors, LLC has filed its 13F form on May 03, 2024 for Q1 2024 where it was disclosed a total value porftolio of $799 Million distributed in 16 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Dyne Therapeutics, Inc. with a value of $228M, Kymera Therapeutics, Inc. with a value of $216M, Day One Biopharmaceuticals, Inc. with a value of $106M, Third Harmonic Bio, Inc. with a value of $103M, and Aerovate Therapeutics, Inc. with a value of $60.3M.

Examining the 13F form we can see an increase of $163M in the current position value, from $636M to 799M.

Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $799 Million
Healthcare: $799 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.65B
$228 Million 28.49% of portfolio
8,020,136
Q1 2024 Reduced 18.87%
$1.76B
$216 Million 27.05% of portfolio
5,377,362
Q1 2024 Reduced 8.21%
$975M
$106 Million 13.29% of portfolio
6,430,257
Q1 2024 Reduced 15.48%
$537M
$103 Million 12.88% of portfolio
10,907,859
Q3 2022 New
$427M
$60.3 Million 7.55% of portfolio
2,039,249
Q1 2023 Added 1.08%
$188M
$33.7 Million 4.22% of portfolio
8,279,484
Q1 2023 Added 0.01%
$89.9M
$19.9 Million 2.49% of portfolio
5,836,874
Q1 2022 New
$260M
$17.1 Million 2.15% of portfolio
2,098,300
Q4 2022 Reduced 32.49%
$64.2M
$7.13 Million 0.89% of portfolio
5,018,178
Q4 2021 New
$64.8M
$5.81 Million 0.73% of portfolio
4,541,381
Q1 2023 Added 0.45%
$49.8M
$1.05 Million 0.13% of portfolio
607,613
Q1 2024 Reduced 40.04%
$29.7M
$1.07 Million 0.13% of portfolio
992,912
Q1 2024 Reduced 64.02%
Q32 Bio, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 New
Disc Medicine, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 10.49%
Dianthus Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 21.1%
Korro Bio, Inc.
-
$0 0.0% of portfolio
-
Q4 2023 New

Summary

  • Portfolio
  • No. of Stocks 16
  • Current Value $799 Million
  • Prior Value $636 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 03, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email